cytarabine has been researched along with Erythremia in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (69.23) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belotti, A; Cecchetti, C; Elli, EM; Fedele, M; Parma, M; Pogliani, EM; Realini, S | 1 |
| Portell, CA; Rogers, HJ; Sekeres, MA; Tiu, RV | 1 |
| Hossfeld, DK; Weh, HJ; Zschaber, R | 1 |
| Arai, Y; Masuda, M; Mizoguchi, H; Motoji, T; Okamura, T; Wada, M | 1 |
| Mollee, PN; Rodwell, R; Taylor, D; Taylor, KM; Williams, B | 1 |
| Barzilai, D; Hazani, A; Tatarsky, I | 1 |
| Meuret, G | 1 |
| Endo, T; Fukumaki, Y; Okano, H; Rutherford, T; Shiokawa, S; Takihara, Y | 1 |
| Domae, N; Kagawa, D; Nakamura, T; Sasada, M; Sugiyama, M; Uchida, M; Uchino, H; Ueda, T; Ueda, Y | 1 |
| Brubaker, LH; Watson, PR; Yaghmai, F | 1 |
| Granatir, RG; Moquin, RB; Perlin, E; Roche, J | 1 |
| Lee, SL; Rosner, F | 1 |
| Goldenberg, DM; Witte, S | 1 |
2 review(s) available for cytarabine and Erythremia
| Article | Year |
|---|---|
Development of JAK2V617F-positive polycythemia vera after chemotherapy-induced remission of primary central nervous system diffuse large B cell non-Hodgkin's lymphoma: a case report and review of the literature.
Topics: Aged; Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Cytarabine; Humans; Janus Kinase 2; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Mutation, Missense; Polycythemia Vera | 2013 |
[Polycythemia vera progressing to acute lymphoblastic leukemia after 13 years].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Female; Humans; Middle Aged; Polycythemia Vera; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Time Factors; Vincristine | 1996 |
11 other study(ies) available for cytarabine and Erythremia
| Article | Year |
|---|---|
De novo polycythaemia vera arising 5 years following acute myeloid leukemia remission: suggestion of a chemotherapy resistant JAK2 clone.
Topics: Amino Acid Substitution; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Resistance, Neoplasm; Female; Humans; Janus Kinase 2; Leukemia, Myeloid, Acute; Middle Aged; Mutation, Missense; Polycythemia Vera | 2012 |
Low-dose cytosine-arabinoside in the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
Topics: Adult; Aged; Bone Marrow Diseases; Bone Marrow Examination; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Polycythemia Vera | 1984 |
Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Disease Progression; Etoposide; Female; Humans; Idarubicin; Karyotyping; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Oncogene Proteins, Fusion; Polycythemia Vera; Preleukemia; Prognosis; Remission Induction; Thrombocythemia, Essential; Thrombophilia; Translocation, Genetic; Tretinoin | 1999 |
Prolonged remission of leukemia associated with polycythemia vera.
Topics: Aged; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Male; Polycythemia Vera; Prednisone; Remission, Spontaneous; Time Factors; Vincristine | 1977 |
Present status of 32P-therapy in management of polycythemia vera.
Topics: Alkylating Agents; Blood Platelets; Bloodletting; Cytarabine; Granulocytes; Hematopoiesis; Humans; Phosphorus Radioisotopes; Polycythemia Vera; Pyrimidines | 1975 |
Differential induction of adult and fetal globin gene expression in the human erythremia cell line KMOE.
Topics: Cell Line; Cytarabine; DNA; Endonucleases; Fetal Hemoglobin; Gene Expression Regulation; Hemoglobin A; Humans; Polycythemia Vera; Single-Strand Specific DNA and RNA Endonucleases; Transcription, Genetic | 1987 |
Clinical pharmacology of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in patients with hematologic malignancies.
Topics: Adult; Aged; Antineoplastic Agents; Arabinofuranosyluracil; Cytarabine; Female; Hematologic Diseases; Humans; Leukemia; Male; Middle Aged; Polycythemia Vera | 1989 |
Severe central nervous system toxicity from high-dose cytarabine: expressive aphasia occurring after the second day of treatment.
Topics: Aphasia; Aphasia, Broca; Cell Count; Cytarabine; Humans; Male; Middle Aged; Polycythemia Vera; Purkinje Cells; Time Factors | 1985 |
Remission of leukemia associated with polycythemia vera.
Topics: Adult; Cytarabine; Daunorubicin; Humans; Leukemia, Myeloid, Acute; Male; Methylprednisolone; Phosphorus Isotopes; Polycythemia Vera; Remission, Spontaneous; Thioguanine; Vincristine | 1973 |
Treatment of AGL.
Topics: Adult; Afibrinogenemia; Aged; Anemia; Antineoplastic Agents; Child; Cytarabine; Daunorubicin; Humans; Hydroxyzine; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Leukopenia; Mercaptopurine; Methotrexate; Middle Aged; Polycythemia Vera; Prednisone; Primary Myelofibrosis; Splenomegaly; Vincristine | 1969 |
The treatment of polycythemia vera with cytosine arabinoside.
Topics: Adult; Aged; Cytarabine; Humans; Middle Aged; Nausea; Polycythemia Vera; Vomiting | 1967 |